Curexo Inc. (KOSDAQ:060280)

Curexo Statistics

Total Valuation

Curexo has a market cap or net worth of KRW 449.52 billion. The enterprise value is 425.16 billion.

Market Cap	449.52B
Enterprise Value	425.16B

Important Dates

The next estimated earnings date is Wednesday, November 12, 2025.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Curexo has 41.09 million shares outstanding.

Current Share Class	41.09M
Shares Outstanding	41.09M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.32%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.32%
Float	28.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	66.11
PS Ratio	16.14
PB Ratio	22.22
P/TBV Ratio	27.09
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-26.33
EV / Sales	15.27
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-9.98

Financial Position

The company has a current ratio of 1.08, with a Debt / Equity ratio of 1.23.

Current Ratio	1.08
Quick Ratio	0.51
Debt / Equity	1.23
Debt / EBITDA	n/a
Debt / FCF	-0.58
Interest Coverage	-113.89

Financial Efficiency

Return on equity (ROE) is -102.15% and return on invested capital (ROIC) is -47.65%.

Return on Equity (ROE)	-102.15%
Return on Assets (ROA)	-44.52%
Return on Invested Capital (ROIC)	-47.65%
Return on Capital Employed (ROCE)	-207.38%
Revenue Per Employee	960.27M
Profits Per Employee	-556.79M
Employee Count	29
Asset Turnover	0.47
Inventory Turnover	1.75

Taxes

In the past 12 months, Curexo has paid 5.33 million in taxes.

Income Tax	5.33M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +59.48% in the last 52 weeks. The beta is 1.01, so Curexo's price volatility has been similar to the market average.

Beta (5Y)	1.01
52-Week Price Change	+59.48%
50-Day Moving Average	8,803.20
200-Day Moving Average	8,850.30
Relative Strength Index (RSI)	69.86
Average Volume (20 Days)	400,301

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Curexo had revenue of KRW 27.85 billion and -16.15 billion in losses. Loss per share was -607.62.

Revenue	27.85B
Gross Profit	2.70B
Operating Income	-42.58B
Pretax Income	-42.79B
Net Income	-16.15B
EBITDA	-39.24B
EBIT	-42.58B
Loss Per Share	-607.62

Balance Sheet

The company has 8.06 billion in cash and 24.93 billion in debt, giving a net cash position of -16.87 billion or -410.49 per share.

Cash & Cash Equivalents	8.06B
Total Debt	24.93B
Net Cash	-16.87B
Net Cash Per Share	-410.49
Equity (Book Value)	20.24B
Book Value Per Share	812.53
Working Capital	2.35B

Cash Flow

In the last 12 months, operating cash flow was -41.18 billion and capital expenditures -1.43 billion, giving a free cash flow of -42.61 billion.

Operating Cash Flow	-41.18B
Capital Expenditures	-1.43B
Free Cash Flow	-42.61B
FCF Per Share	-1,037.01

Margins

Gross margin is 9.70%, with operating and profit margins of -152.90% and -57.98%.

Gross Margin	9.70%
Operating Margin	-152.90%
Pretax Margin	-153.64%
Profit Margin	-57.98%
EBITDA Margin	-140.90%
EBIT Margin	-152.90%
FCF Margin	n/a

Dividends & Yields

Curexo does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.21%
Shareholder Yield	0.21%
Earnings Yield	-3.59%
FCF Yield	-9.48%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 5, 2006. It was a forward split with a ratio of 2.

Last Split Date	Apr 5, 2006
Split Type	Forward
Split Ratio	2

Scores

Curexo has an Altman Z-Score of -1.46. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.46
Piotroski F-Score	n/a